|
IKT Inhibikase Therapeutics Inc 1750149 |
| Balance Sheet |
|
Current Assets
|
4,190,103 |
|
Assets
|
4,376,875 |
|
Current Liabilities
|
4,907,466 |
|
Liabilities
|
4,907,466 |
|
Equity
|
-530,591 |
|
Shares Out
|
7,464,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-13,802,492 |
|
Investing Cash Flow
|
1,757,524 |
| Market Analysis |
Market Cap
|
9,315,155 |
|
Price
|
2.41 |
|
BVPS
|
3.11 |
|
PB
|
0.80 |
|
EPS
|
-2.93 |
|
PS
|
1.63 |
|
FCF
|
-12,044,968 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IKT documents filed with the SEC.
IKT Filings
Clear
